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Objective: To investigate the relationship between disease-
related factors and walking disability in different phases of 
rheumatoid arthritis; and to predict future walking disabil-
ity in rheumatoid arthritis, using disease-related factors as-
sessed 2 years after diagnosis.
Methods: A cohort of 848 newly diagnosed patients with 
rheumatoid arthritis was followed up for a maximum of 8 
years. Walking disability and several disease-related and de-
mographic factors were recorded during follow-up. A logis-
tic regression model was used to study associations between 
walking disability and these factors at different time points. 
A multilevel logistic regression model for longitudinal data 
was used to predict walking disability during follow-up from 
potential predictors at year 2. 
Results: Global pain and disease activity were consistently 
related to walking disability at almost every time point. Sig-
nificant predictors of future walking disability were: walk-
ing disability, knee pain, global pain, the passage of time 
during follow-up, and age. 
Conclusion: Global pain and disease activity are related to 
walking disability during the first 8 years of RA. Walking 
disability, knee pain, and global pain at 2 years follow-up 
predict walking disability later in the disease. In addition, 
the risk for walking disability increases during the disease 
process and with higher age at diagnosis.
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INTRODUCTION
Walking disability is common in rheumatoid arthritis (RA). 
In a recent longitudinal study by our research group, walking 
disability was present in 57% of patients at initial disease 
presentation, and varied by around 40% from year 1 to year 8 
as measured by the walking subscale of the Health Assessment 
Questionnaire (HAQ) (1).
Factors associated with walking disability throughout the 
course of RA have rarely been studied. Disease-related impair-
ments of the lower extremities, such as pain, swelling, joint 
damage, decreased muscle strength and limited joint mobility, 
are thought to be associated with walking disability in RA. 
However, associations between disease-related impairments 
and walking disability have been investigated in only one study 
(2). In that cross-sectional study of patients with RA, with a 
mean disease duration of 6 years (range 0–44 years), global 
pain, swollen joints of the lower extremities and knee flexion 
were associated with the HAQ walking subscale. 
Factors associated with general functional disability (as 
expressed by the HAQ total score) have been studied more fre-
quently. Disease-related factors, such as disease activity, joint 
damage and rheumatoid factor, but also factors such as gender, 
age, psychological status, muscle strength and comorbidities, 
were found to be associated with functional disability (3–13). 
There is evidence that the association between disease-related 
factors and functional disability varies depending on the phase 
of RA. In early disease (disease duration < 5 years), functional 
disability was found to be related to disease activity in particu-
lar. In established disease (disease duration > 5 years) functional 
disability was found to be related mainly to joint damage (4, 
12, 13). The question arises as to whether such differences in 
associations can also be found when relating walking disability 
and specific disease-related factors in RA. 
To date, the predictors of walking disability are unknown. 
Both patients and clinicians value the ability to predict future 
walking disability, because knowledge of predictors may 
be important for planning (conservative) treatment aimed 
at reducing the level of walking disability. The purpose of 
the present study was to determine simple, easily accessible 
predictors that allow the prediction of walking disability in 
clinical practice. 
The aims of the present study were: (i) to investigate the 
relationship between disease-related factors and walking dis-
ability in different phases of rheumatoid arthritis (RA); and (ii) 
to predict future walking disability in RA, using disease-related 
factors assessed 2 years after diagnosis.
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METHODS
Study design
Since 1995, patients in The Netherlands aged 18 years and older with 
recent onset arthritis (peripheral arthritis of more than 2 joints and 
symptom duration of less than 3 years) have been included in an Early 
Arthritis Cohort (EAC) (14). This cohort was established in 1995 to 
study a wide variety of arthritis research topics, including the presence 
and course of the signs and symptoms of the disease process. Patients 
who were already treated with Disease-modifying antirheumatic drugs 
(DMARDs), as well as patients with crystal synovitis, osteoarthritis, 
psoriatic arthritis and spondylarthropathy were excluded. By May 2007 
a total of 1622 patient had been followed up. Among other measure-
ments, patients’ disease activity, joint damage by scoring radiographs, 
and functional disability have been assessed at different time points. 
For the present study all patients fulfilling the 1987 American College 
of Rheumatology (ACR; formerly the American Rheumatism Associa-
tion) criteria for RA (15) at baseline and/or at 1 year after inclusion 
were selected. Data of annual assessments were used, with a maximum 
of 8 years of follow-up. 
Patient selection
A total of 848 (52%) patients fulfilled the ACR criteria for RA within 
the first year and were included in the study. All of these patients 
had at least a baseline measurement. The duration of follow-up 
varied between patients, as patients have been included from 1995 
through May 2007. A total of 682 patients had a follow-up of 1 year, 
341 patients had a follow-up of 4 years, and 121 patients had a full 
follow-up of 8 years. Our earlier report on the same cohort analysed 
drop-out from the cohort. The most common reasons for dropping out 
were: insufficient time (n = 81), moving to another area (n = 46), and 
disease remission (n = 37). 
Drug treatment decisions were made by the rheumatologists accord-
ing to clinical practice standards.
Measures
Dependent variable.
• Walking disability: for the assessment of walking disability one 
category of the Health Assessment Questionnaire (HAQ) disability 
index (16), i.e. walking (walking outdoors on flat ground, climbing 
up 5 steps), was used. The HAQ walking subscale (HAQ-walking) 
produces a score between 0 (no disability) and 3 (severe disability). 
Walking disability was regarded as absent if the score = 0 and as 
present if the score ≥ 1. The dichotomized score was used in the 
analyses. 
Independent variables.
• Pain and swelling of joints of the lower extremity. Pain by palpation 
and the presence or absence of swelling of joints were assessed by a 
trained clinical research assistant. For the present study measurements 
of pain and swelling of the lower extremity, including the number of 
painful and swollen metatarsophalangeal (MTP) joints (range 0–10 
for both pain and swelling) and pain and swelling of the knee joints 
(range 0–2 for both pain and swelling) were used. Pain in these joints 
was regarded as absent if the score for pain was 0 and present if the 
score ≥ 1. The same approach was used for swelling. The dichotomized 
scores (score 0 vs score ≥ 1) were used in the analyses.
• Joint damage of MTP and interphalangeal (IP) joints. For a subgroup 
of patients with a follow-up of at least 2 years (n = 539 at baseline), 
joint damage of the hands and feet on radiographs was assessed by 2 
trained rheumatologists using the Sharp/van der Heijde method (17). 
The consensus between the 2 rheumatologists was high (Pearson’s cor-
relation of 0.84, p < 0.01, calculated for a subgroup of 67 radiographs). 
The score for the feet included a score for erosions (range 0–10 per 
joint) and a score for joint space narrowing (range 0–4 per joint) of the 
10 MTP joints and the 2 IP joints of the big toes. Therefore, the total 
score for erosion in both feet ranges from 0 to 120 and the total score 
for joint space narrowing in both feet ranges from 0 to 48. Erosion 
of the feet was regarded as absent if the score for erosion was 0 and 
present if the score ≥ 1. The same approach was used for joint space 
narrowing. The dichotomized scores (score 0 vs score ≥ 1) were used 
in the analyses.
• Other variables. Gender, age at baseline, the absence (= 0) or pres-
ence (= 1) of IgM rheumatoid factor, symptom duration at baseline, the 
disease activity score that includes a 28-joint count and the erythrocyte 
sedimentation rate (mm/h) (DAS28; range 2–10) (18) and global pain 
assessed on a 100-mm visual analogue scale (VAS), were recorded. 
Statistical analysis
Descriptive statistics were calculated for basic demographic and disease-
related characteristics of the patients at baseline. Descriptive statistics 
of potential predictors of walking disability at 2 years follow-up were 
also calculated. The choice for predictors at 2 years follow-up was made 
because medication is supposed to be adjusted at that time. 
Univariate logistic regression analyses at baseline and 2, 4, 6 and 
8 years follow-up were performed with the dichotomized score of 
the HAQ-walking subscale as the dependent variable. Independent 
variables were: knee pain, knee swelling, MTP pain, MTP swelling, 
forefoot erosion, and forefoot joint space narrowing. These scores were 
dichotomized for their use in the analyses (0 = absent and 1 = present). 
Other independent variables were: gender, age at baseline (per 10 
years), symptom duration at baseline, rheumatoid factor, VAS global 
pain (per 10 mm) and DAS28. Multivariate logistic regression models 
were constructed at 0, 2, 4, 6 and 8 years. p was set at < 0.20 for entering 
the models. Backwards selection using the likelihood ratio statistic of 
p < 0.05 to stay in the model was used to select the best variables.
Multilevel logistic regression analysis for longitudinal data (19) was 
performed with the dichotomized score of the HAQ-walking subscale 
from years 3 to 8 as the dependent variable. Potential predictors at year 
2 were: walking disability, knee pain, knee swelling, MTP pain, MTP 
swelling, forefoot erosion, forefoot joint space narrowing, DAS28, 
VAS global pain (per 10 mm) and rheumatoid factor. In addition, 
gender, age at baseline (per 10 years), and the passing of time dur-
ing follow-up were included as predictors. For the interpretability of 
the last predictor (time), years 3 to 8 were recoded into years 0 to 5. 
Interactions between time and the final predictors were analysed by 
forming interaction terms. A significance level of p < 0.05 was used 
to stay in the model. Odds ratios (ORs) with 95% confidence intervals 
were calculated for the final predictors. 
All analyses were performed using SPSS (version 15.0), except for 
the multilevel logistic regression analysis for longitudinal data, which 
was performed using Stata (version 10.0; procedure xtmelogit with 30 
adaptive quadrature points). 
RESULTS
Descriptive analyses
Baseline patient characteristics are shown in Table I. Walking 
disability was present in 57% of the patients. 
Values of potential disease-related predictors of walking dis-
ability at 2 years follow-up are shown in Table II. Data for 558 
patients were present at year 2. The prevalence of patients with 
walking disability decreased to 36%. At clinical examination, 
45% of patients had pain in at least one MTP joint, compared 
with 15% of patients who had pain in at least one knee joint. 
On radiographs, 39% of patients had at least one erosion of the 
forefoot. The mean DAS28 decreased to 3.2 (SD 1.3). 
Associations with walking disability at various time points
In the univariate logistic regression analyses at 0, 2, 4, 6 and 
8 years, the following variables were associated with HAQ-
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walking at p < 0.20 at all time points: knee pain, MTP pain, 
MTP swelling, DAS28 and VAS-global pain. Knee swelling 
was associated with HAQ-walking at 0, 2, 4 and 6 years, age 
and gender at 4 years only, and rheumatoid factor at 6 years 
only (at p < 0.20). For the multivariate logistic regression analy-
ses per time point these variables were entered in the model. 
The results of the multivariate analyses are shown in Table III. 
Only variables that showed a significant association with 
HAQ-walking are presented. VAS-global pain was associated 
with HAQ-walking at every studied time point during the first 
8 years of RA. DAS28 was associated with HAQ-walking at 
every studied time point, except for year 8. Knee pain, knee 
swelling, MTP pain, and age were associated with HAQ-walk-
ing at one or more time points. Forefoot erosion and forefoot 
joint space narrowing were not significantly associated with 
HAQ-walking at any studied time point. 
Predictors of future walking disability
Table IV shows the final prediction model derived from the 
multilevel logistic regression analysis for longitudinal data. 
HAQ-walking during follow-up (years 3 to 8) was predicted 
by the following disease-related variables at year 2: HAQ-
walking, knee pain and VAS-global pain. Furthermore, age and 
the passage of time during follow-up predicted future walk-
ing disability. A significant effect for the interaction between 
HAQ-walking at year 2 and time was found, which means 
that, for the patients with walking disability at year 2, the risk 
for walking disability later in the disease remained constant 
(OR = 0.94, 95% confidence interval (CI) 0.84–1.16), whereas, 
for patients without walking disability at year 2, the risk for 
walking disability increased over time (OR = 1.23, 95% CI 
1.05–1.44). The negative value of the interaction term means 
a decreasing effect of HAQ-walking at year 2 over time. There 
was no significant effect for cohort (i.e. year of inclusion in the 
EAC). Furthermore, no random time effect was found.
DISCUSSION
The results show that global pain was associated with walking 
disability at all studied time points during the first 8 years of 
the disease. This finding is in accordance with other studies, 
in which strong associations between pain and general func-
tional disability, both in the early and established stages of 
RA, were found (2, 3, 20–22). In a cross-sectional study of 
Häkkinen et al. (2), using RA patients with a mean disease 
duration of 6 years, all subdimensions of the HAQ, including 
the HAQ walking subscale, were associated with global pain. 
It can be concluded that pain makes an important contribution 
to both general functional disability and walking disability.
Furthermore, DAS28 (all years except for year 8), knee pain, 
knee swelling and MTP pain (at several time points) were as-
sociated with walking disability. This means that both global 
disease activity and disease activity in lower extremity joints 
affect walking ability. 
The presence of forefoot joint damage was not associated 
with walking disability during the first 8 years of the disease. 
In line with our findings, Häkkinen et al. (2) found that fore-
foot joint damage was not associated with the HAQ walking 
subscale. General functional disability (as measured with the 
total HAQ score) was found to be particularly related to disease 
activity in early disease (disease duration < 5 years), whereas 
Table I. Patient characteristics at baseline (n = 848)
Characteristics Value
Female, % 69
Age, years, mean (SD) 55.2 (14.2)
Duration of symptoms, median (IQR) 0.0 (0.0–1.0)
Rheumatoid factor positive, % 51.3
DAS28, mean (SD) 5.2 (1.2)
Walking disability present, % 57
IQR: interquartile range; DAS28: disease activity score in 28 joints; 
SD: standard deviation.
Table II. Values of potential disease-related predictors at 2 years 
follow-up
Value n
Walking disability present, % 36.4 492
Knee pain present, % 15.4 558
Knee swelling present, % 7.9 558
MTP pain present, % 44.8 558
MTP swelling present, % 37.5 558
Forefoot erosion present, % 39.3 517
Forefoot joint space narrowing present, % 28.6 517
DAS28, mean (SD) 3.2 (1.3) 525
VAS-global pain, mean (SD) 29.9 (24.4) 532
n: number of patients evaluated; MTP: metatarsophalangeal joint; 
DAS28: disease activity score in 28 joints; VAS: visual analogue scale; 
SD: standard deviation.
Table III. Results of multivariate logistic regression analyses of walking disability with significant variables at 0, 2, 4, 6, and 8 years
Variable
Baseline 
(n = 808)
OR (95% CI)
Year 2
(n = 482)
OR (95% CI)
Year 4
(n = 290)
OR (95% CI)
Year 6
(n = 123)
OR (95% CI)
Year 8
(n = 89)
OR (95% CI)
Knee pain 1.98 (1.35–2.90) 2.78 (1.30–5.95) 5.56 (1.28–24.14)
Knee swelling 1.78 (1.21–2.63)
MTP pain 1.47 (1.05–2.06) 2.93 (1.08–7.95)
Age/10 years 1.27 (1.00–1.61)
DAS28 1.50 (1.28–1.76) 1.66 (1.36–1.98) 1.53 (1.16–2.03) 1.97 (1.14–3.40)
VAS-global pain/10 mm 1.14 (1.05–1.23) 1.09 (1.00–1.21) 1.38 (1.20–1.58) 1.39 (1.10–1.76) 1.45 (1.14–1.83)
OR: odds ratio; CI: confidence interval; MTP: metatarsophalangeal joint; DAS28: disease activity score in 28 joints; VAS: visual analogue scale. 
Dependent variable: HAQ-walking (0,1).
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in established disease (disease duration > 5 years) functional 
disability was found to be related mostly to joint damage (4, 
12, 13). The present study did not show this pattern for walking 
disability in the first 8 years of RA. This finding might be due 
to improvements in medication in recent years, which have 
resulted in better control over joint damage. The contribution 
of joint damage to functional disability might appear later in 
the disease process. 
Several disease-related factors at 2 years follow-up (i.e. 
walking disability, knee pain and global pain), age and the 
passage of time during follow-up predicted walking disability 
later in the disease. 
The odds ratio for walking disability at 2 years follow-up 
was high, meaning that the presence of walking disability at 
year 2 was a strong predictor for walking disability later in the 
disease. This is in accordance with the literature regarding the 
prediction of general functional ability, where functional ability 
at baseline seems to be the most consistent prognostic factor 
of functional ability later in the disease (14, 23–26).
Knee pain at 2 years follow-up was shown to be a predictor 
for future walking disability, while the presence of forefoot 
pain did not predict walking disability. This might indicate that 
involvement of the large joints of the lower extremity has more 
impact on walking disability than involvement of the small 
joints. Further research is needed to confirm this finding.
Higher global pain at 2 years follow-up predicted future 
walking disability. An explanation for this finding could be 
that pain is reported by the patient, as is walking disability. 
Observed disease-related factors, i.e. rheumatoid factor and 
DAS28, did not predict future walking disability. This finding 
suggests that patient-reported factors might be more relevant 
than observed factors for the consequences of the disease.
A higher age and the passage of time during follow-up were 
found to be predictors of future walking disability, meaning an 
increase in the risk of walking disability with age and during 
the disease process. Sokka et al. (27) also found age to be a 
factor in the progression of functional disability. They analysed 
longitudinal data over 5 years for changes in the HAQ scores 
in patients with RA and age- and sex-matched controls from 
the general population and concluded that progression of func-
tional disability among patients with RA and among persons 
in the general population is largely explained by the ageing 
process (27). Finally, a significant interaction effect with time 
for walking disability at year 2 was found. This means that for 
patients with walking disability at 2 years follow-up the risk for 
experiencing walking disability later in the disease remained 
constant, whereas for patients without walking disability at 
year 2 the risk for walking disability increased with time. 
The choice for predictors at 2 years after initial disease 
presen tation was made as medication is supposed to be adjusted 
at that time. In our earlier study (1) using data of the same 
cohort we found an improvement in disease-related variables 
(i.e. walking disability, disease activity, joint pain and joint 
swelling) from initial presentation to 2 years follow-up. From 
year 2 to year 8 these values were rather stable. For this reason, 
we used variables at 2 years after initial disease presentation 
to predict walking ability.
The presence of walking disability at 2 years follow-up 
strongly predicted future walking disability. Thus, a patient 
with walking disability at 2 years of follow-up is likely also 
to have walking disability later during follow-up. Walking 
disability at 2 years follow-up is therefore a reason to consider 
(conservative) treatment for lower extremity impairments and 
walking disability, including physiotherapy and podiatry. 
There are some limitations of the present study. First, no 
measurements of pain, swelling and joint damage in other foot 
joints than the forefoot joints were recorded in the Early Arthritis 
Cohort (EAC). The EAC also lacks measurements of hip involve-
ment. This limits the results of the present study regarding the 
impact of lower extremity involvement on walking disability. 
In addition, no questionnaire specifically designed to measure 
lower extremity functioning was used. Instead, a subscale of the 
HAQ was used to measure weight-bearing functioning. How-
ever, the advantage of the HAQ is that it is the most common 
functional measure in rheumatology, and is easily accessible in 
rheumatology practice. Häkkinen et al. (2) showed a high inter-
nal consistency of the walking subscale (Crohnbach’s α = 0.82, 
95% 1-sided CI = 0.78). The Crohnbach’s α of the HAQ-subscale 
in our study was 0.88 (95% CI 0.86–0.90). 
Furthermore, dichotomizing the major variables used in the 
present study reduces the information available in these vari-
ables. On the other hand, dichotomization makes interpretation 
of the results easier and therefore more useful for daily practice. 
More details of the variables included in the present study can 
be found in our earlier report (1). 
Finally, there are some limitations of the use of an open 
cohort, e.g. the drop-out rate, and the heterogeneity of medi-
cations. These limitations have been addressed extensively in 
Table IV. Results of multilevel logistic regression analysis of walking disability (from years 3 to 8) with significant variables
Variable B Odds ratio 95% CI OR p-value
Intercept (SD) –4.88 (2.22) – – –
HAQ-walking at year 2 3.90 49.38 19.26–126.65 < 0.001
Pain knee at year 2 1.08 2.95 1.13–7.01 0.014
VAS-global pain/10 mm at year 2 0.23 1.26 1.09–1.46 0.002
Age/10 years 0.26 1.30 1.01–1.67 0.043
Time* 0.21 1.23 1.05–1.44 0.010
HAQ-walking at year 2 × time –0.27 0.76 0.59–0.99 0.044
*Time = 0 equals 3 years follow-up; dependent variable: HAQ-walking from years 3 to 8 (0,1).
B: regression coefficient; CI: confidence interval; SD: standard deviation; HAQ: Health Assessment Questionnaire; VAS: visual analogue scale.
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our earlier report on the same cohort (1). Selection bias due to 
drop-out was concluded to be minimal. Also, the heterogeneous 
medical treatment history of patients with RA in our cohort, 
with a start in 1995, has been acknowledged. Biologics were 
introduced, around 2001 with possible effects on the frequency 
of foot impairments and walking disability.
In conclusion, global pain and disease activity are related 
to walking disability during the first 8 years of RA, and joint 
damage is not. Walking disability, knee pain and global pain 
at 2 years follow-up predict walking disability later in the 
disease. In addition, the risk for walking disability increases 
during the disease process and with higher age.
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